SCRI has many ongoing clinical trials. Participation in a clinical trial is the first step in fighting cancer, not the last.®
SCRI uses a network model, with more than 700 community-based oncologists across 25 states and the United Kingdom, making our trials easily accessible to a broad patient base.
Balancing science, care and committment, SCRI is proud to promote partnership with community physicians and academic institutions.
NewsSee All News >>
Aug 20 New Blood Cancer Outpatient Treatment Clinic Opened in May At...
Jul 1 Sarah Cannon Research Institute (SCRI) and AstraZeneca (AZ) announced...
May 30 Institutional record of 78 abstracts accepted for presentation